Thread regarding immunosuppression in the wake of #COVID19 and a significant influenza season:
Current advice from @ACRheum regarding :
"While there are no data on the influence of these medications on COVID-19, providers should follow their current practice for interrupting therapy during episodes of infection."
#ACR19 Review Course — Update in RA Therapy 2019 — Dr. Michael Weinblatt.
My notes in thread ⬇️⬇️⬇️
SQ MTX offers the advantage of delivering 100% of the med to the patient.
Split dose oral MTX also increase bioavailability >28% over single dose.
Also important to make sure you escalate the dose of MTX up to 20-25mg/wk. #ACR19
Apr 4, 2019 • 27 tweets • 12 min read
Here is my attempt at organizing the massive number of replies to my request for physicians on Twitter to follow for my #MPLSVAGrandRounds talk “Social Media in Medicine”
Here is the original thread, which has lists of people in just about every specialty you could think of, and quickly went beyond my ability to organize.